The impaired USP44-TRIM25-KU80 axis is supposed to act as a major pathway of resistance of NPC and probably other human cancers towards ionizing radiation, and therefore, offers an attractive target for novel resensitizing tumor therapies. The gene discussed is TRIM25; the disease is neoplasm.